Mid-pregnancy serum chemerin levels predict persistence of postpartum hypertension in patients with polycystic ovary syndrome

European Journal of Endocrinology · Published 2026-06-01 · DOI 10.1093/ejendo/lvag102

Authors (10)

Stefano Palomba, Giuseppe Seminara, Flavia Costanzi, Rossella Cannarella, Tiziana Russo, Martina Sarica, Fabrizio Signore, Donatella Caserta, Aldo E. Calogero, Antonio Aversa

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Palomba, S., Seminara, G., Costanzi, F., et al. (2026). Mid-pregnancy serum chemerin levels predict persistence of postpartum hypertension in patients with polycystic ovary syndrome. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvag102

Related articles

• Safety of glucagon-like peptide-1 receptor agonists in neuroendocrine neoplasms · European Journal of Endocrinology · 2026 · Same journal
• Integrated Clinical–Genetic–Pathological Analysis Expands the Phenotypic and Molecular Spectrum of PPNAD Across Carney Complex and Isolated Forms · European Journal of Endocrinology · 2026 · Same journal
• Changes in serum TSH across the adult lifespan: 22-year follow-up of the HUNT Study · European Journal of Endocrinology · 2026 · Same journal
• Independent clonal evolution in primary pigmented nodular adrenocortical disease: a single-patient multi-omics study · European Journal of Endocrinology · 2026 · Same journal
• Baseline biochemical evaluation for etiologic differentiation in ACTH-dependent Cushing’s syndrome: machine learning and composite score analysis in a multicenter cohort of 566 patients. · European Journal of Endocrinology · 2026 · Same journal
• From concept to protocol: iterative approach of a target trial emulation on GnRH analog safety in transgender and gender diverse youth · European Journal of Endocrinology · 2026 · Same journal
• Magnesium as an endocrine modulator: physiological roles, clinical evidence, and therapeutic perspectives · European Journal of Endocrinology · 2026 · Same journal
• Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment · European Journal of Endocrinology · 2026 · Same journal
• Targeted proteomics reveals novel biomarkers of disease activity and inflammation in acromegaly · European Journal of Endocrinology · 2026 · Same journal
• Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men · European Journal of Endocrinology · 2026 · Same journal